Self-propagating high-temperature synthesis of high porosity foam materials in microgravity

Ceramic and metalloceramic foam materials are important construction, building, and thermal insulation materials for space stations of the 21st century. Delivery of these materials from Earth to space using rockets is not profitable due to the low density of these materials. Production of foam materials in space using traditional methods requires large energy consumption. Using SHS in space solves this problem

~115 GeV and ~143 GeV Higgs mass considerations within the Composite Particles Model

The radiatively generated Higgs mass is obtained by requiring that leading "divergences" are cancelled in both 2D and 4D. This predicts one or more viable modes; the k=1 mode mass is m_H\cong2/3 m_t\cong115GeV whereas the k=2 mode is m_H\cong143GeV. These findings are interpreted within the Composite Particles Model (CPM), [Popovic 2002, 2010], with the massive top quark being a composite structure composed of 3 fundamental O quarks (O\bar{O}O) and the massive Higgs scalar being a color-neutral meson like structure composed of 2 fundamental O quarks (\bar{O}O). The CPM predicts that the Z mass generation is mediated primarily by a top - anti top whereas the Higgs mass is generated primarily by a O - anti O interactions. The relationship [Popovic 2010] between top Yukawa coupling and strong QCD coupling, obtained by requiring that top - anti top channel is neither attractive or repulsive at tree level at \surd s\congM_Z, defines the Z mass. In addition, this relationship indirectly defines the electroweak symmetry breaking (EWSB) vacuum expectation value (VEV), the CPM Higgs mass and potentially the EWSB scale.Comment: 11 pages, 3 figures, slightly updated second version: Lagrangian explicitly specified, OOO->O\bar{O}O and a few other typos correcte

Adaptive pseudolinear compensators of dynamic characteristics of automatic control systems

Adaptive pseudolinear gain and phase compensators of dynamic characteristics of automatic control systems are suggested. The automatic control system performance with adaptive compensators has been explored. The efficiency of pseudolinear adaptive compensators in the automatic control systems with time-varying parameters has been demonstrated

Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

\ua9 2024 The AuthorsBackground: Asthma is commonly reported in patients with a diagnosis of bronchiectasis. Objective: The aim of this study was to evaluate whether patients with bronchiectasis and asthma (BE+A) had a different clinical phenotype and different outcomes compared with patients with bronchiectasis without concomitant asthma. Methods: A prospective observational pan-European registry (European Multicentre Bronchiectasis Audit and Research Collaboration) enrolled patients across 28 countries. Adult patients with computed tomography–confirmed bronchiectasis were reviewed at baseline and annual follow-up visits using an electronic case report form. Asthma was diagnosed by the local investigator. Follow-up data were used to explore differences in exacerbation frequency between groups using a negative binomial regression model. Survival analysis used Cox proportional hazards regression. Results: Of 16,963 patients with bronchiectasis included for analysis, 5,267 (31.0%) had investigator-reported asthma. Patients with BE+A were younger, were more likely to be female and never smokers, and had a higher body mass index than patients with bronchiectasis without asthma. BE+A was associated with a higher prevalence of rhinosinusitis and nasal polyps as well as eosinophilia and Aspergillus sensitization. BE+A had similar microbiology but significantly lower severity of disease using the bronchiectasis severity index. Patients with BE+A were at increased risk of exacerbation after adjustment for disease severity and multiple confounders. Inhaled corticosteroid (ICS) use was associated with reduced mortality in patients with BE+A (adjusted hazard ratio 0.78, 95% CI 0.63-0.95) and reduced risk of hospitalization (rate ratio 0.67, 95% CI 0.67-0.86) compared with control subjects without asthma and not receiving ICSs. Conclusions: BE+A was common and was associated with an increased risk of exacerbations and improved outcomes with ICS use. Unexpectedly we identified significantly lower mortality in patients with BE+A

A BEAT-PCD consensus statement:a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

BACKGROUND: Consistent use of reliable and clinically appropriate outcome measures is a priority for clinical trials, with clear definitions to allow comparability. We aimed to develop a core outcome set (COS) for pulmonary disease interventions in primary ciliary dyskinesia (PCD).METHODS: A multidisciplinary international PCD expert panel was set up. A list of outcomes was created based on published literature. Using a modified three-round e-Delphi technique, the panel was asked to decide on relevant end-points related to pulmonary disease interventions and how they should be reported. First, inclusion of an outcome in the COS was determined. Second, the minimum information that should be reported per outcome. The third round finalised statements. Consensus was defined as ≥80% agreement among experts.RESULTS: During the first round, experts reached consensus on four out of 24 outcomes to be included in the COS. Five additional outcomes were discussed in subsequent rounds for their use in different subsettings. Consensus on standardised methods of reporting for the COS was reached. Spirometry, health-related quality-of-life scores, microbiology and exacerbations were included in the final COS.CONCLUSION: This expert consensus resulted in a COS for clinical trials on pulmonary health among people with PCD.</p